The trial posting for Efficacy and Safety of 3-Week Fixed Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated with Bipolar I Disorder is not listed as active in clinicaltrials.partners.org database. The trial may have stopped recruiting.